MicroRNA-29b-3p degenerates terminally differentiated dopaminergic SH-SY5Y cells by perturbation of mitochondrial

Sana Sarkar1,2, Anuj Pandey1,3, Sanjeev Kumar Yadav1

  • 1Systems Toxicology Group, Food, Drug & Chemical, Environment and Systems Toxicology (FEST) Division, CSIR- Indian Institute of Toxicology Research (CSIR-IITR), Lucknow, UP, India.

Journal of Neurochemistry
|February 27, 2024
PubMed

Insights

Neurotoxicants increase miR-29b-3p, a microRNA linked to Parkinson's disease. This dysregulation impairs mitochondrial function and causes dopaminergic neuron degeneration by affecting key regulatory pathways.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Mitochondrial dysfunction is a key factor in neurodegeneration, with links to neurotoxicant exposure and altered microRNA (miRNA) expression.
  • MiRNAs play a role in regulating mitochondrial homeostasis and bioenergetics.
  • miR-29b-3p is significantly upregulated in Parkinson's disease patients' blood.

Purpose of the Study:

  • To investigate the role of miR-29b-3p in neurotoxicant-induced dopaminergic cell degeneration.
  • To elucidate the mechanisms by which miR-29b-3p affects mitochondrial function and neuronal apoptosis.

Main Methods:

  • Differentiated dopaminergic SH-SY5Y cells were exposed to neurotoxicants (arsenic or rotenone).
  • miR-29b-3p expression levels were measured.
  • Mitochondrial morphology, oxidative stress, membrane potential, and bioenergetics (oxygen consumption rate) were assessed.
  • Apoptosis pathways involving SIRT-1/YY-1/PGC-1α were investigated.

Main Results:

  • Neurotoxicants significantly increased miR-29b-3p expression in dopaminergic cells.
  • Elevated miR-29b-3p impaired mitochondrial morphology, increased oxidative stress, and reduced mitochondrial membrane potential.
  • Overexpression of miR-29b-3p decreased mitochondrial respiration parameters (OCR, maximal, basal, and non-mitochondrial respiration).
  • Inhibition of miR-29b-3p restored mitochondrial respiration.
  • miR-29b-3p induced apoptosis via the SIRT-1/YY-1/PGC-1α pathway.

Conclusions:

  • miR-29b-3p is a critical mediator of neurotoxicant-induced mitochondrial dysfunction and dopaminergic neuron degeneration.
  • The study identifies miR-29b-3p as a potential therapeutic target for Parkinson's disease and related neurodegenerative disorders.
  • The findings highlight the intricate regulation of mitochondrial bioenergetics by miRNAs in neurodegeneration.